Cancer

A study conducted by researchers at the University of Washington School of Medicine has found that the higher presence of a certain type of bacteria in a gut chrome indicates a higher chances of colon polyps turning cancerous. The study was done on 40 patients who had taken regular colonoscopies...

According to new research, it is possible to prepare the immunity system against certain proteins called neoantigens beforehand to increase the response of the T cells and shrink cancer cells before they mature. A study published in the Cell says, researchers from the MIT and Koch Institute for...

A study conducted among cancer patients in Russia has found that those who quit smoking after a diagnosis of early-stage lung cancer live for a longer time. The findings of the study revealed that if cancer patients quit smoking, there is a good chance of their cancer not returning or taking a turn for...

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health has revealed that vaccination against the human papillomavirus or HPV, which is a major cause of throat and back of mouth cancers, will not yield any significant results until after the year 2045. Globally, HPV is...

Researchers at the National Cancer Institute or NCI may have decoded the reason why many non-smokers are falling sick with lung cancer. Their research has shown that in people with no smoking history, the cancerous cells grow and multiply from the accumulation of mutations caused by natural processes...

Researchers at the McGill University have identified proteins, which fuel the growth of cancer stem cells. In the case of aggressive brain cancers like glioblastoma, the main cause is a particular protein known as galectin. According to researchers, identifying and suppressing this particular protein,...

Researchers at the Duke Cancer Institute have discovered that breast cancer cells make use of cholesterol to build resistance to stress, thus making them immune to treatment as they move away from their original position. The research went into depth to understand the mechanism by which the breast cancer...

NXP800, an investigational cancer drug that inhibits the Heat Shock Factor-1 developed by the Institute of Cancer Research (ICR) in London, is going to enter the phase I clinical trials. The drug has shown promise in the pre-clinical stages by stopping cancer growth in culture and also regressed...

Research done at the Linköping University in Sweden has revealed that an in-use drug, 5-azacytidine, can be used as a targeted therapy for children suffering from acute lymphoblastic leukemia (ALL). The latest study has found that the tumor-inhibiting gene TET2 is not active in majority of children...

A new study done by researchers at the University of Virginia School of Medicine's Department of Public Health Sciences has revealed that the commonly used blood pressure drugs have potential to improve the survival rate of patients suffering from colorectal cancer. The study was conducted on more than...

Increasing intake of Vitamin D might help preventing early-onset of colorectal cancer in young people, according to a new study. Consuming higher amounts of vitamin D can protect against developing young-onset colon cancer, according to study recently by scientists from Dana-Farber Cancer Institute,...

Researchers are now considering aspirin as a potential treatment for an aggressive type of breast cancer. They are hoping that this cheap and readily available drug, when administered along with immunotherapy, will turn out to be life-saving for patients suffering from triple-negative breast cancer....

Histone deacetylase inhibitors improve the efficacy of immunotherapy in patients with advanced stages of cancer who do not respond to traditional treatments, according to a collaborative study by cancer research institutes in the US and Ireland published in Clinical Research Center. The researchers,...

According to a work published in Nature Biomedical Engineering magazine, bio-engineers at the University of California San Diego are working to develop a safe and effective way of treating cancerous tumors, using the chimeric antigen receptor (CAR) T-cell therapy, which is expected to abate the growth...

North Carolina Scientists have come up with a new treatment method to cure mast cell cancer by mutating the messenger RNA (mRNA). The process, named Frameshifting, will reduce the number of mast cells by changing the mRNA before it can instruct the production of c-KIT gene that causes rapid increase. According...